...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Control of Advanced Choroid Plexus Tumors in SV40 T Antigen Transgenic Mice Following Priming of donor CD8~+ T Lymphocytes by the Endogenous tumor Antigen
【24h】

Control of Advanced Choroid Plexus Tumors in SV40 T Antigen Transgenic Mice Following Priming of donor CD8~+ T Lymphocytes by the Endogenous tumor Antigen

机译:内源性肿瘤抗原启动供体CD8〜+ T淋巴细胞后,对SV40 T抗原转基因小鼠晚期脉络膜丛肿瘤的控制

获取原文
获取原文并翻译 | 示例

摘要

Mouse models in which tumors spontaneously due to the transgenic expression of an oncoprotein provide an opportunity to test approaches that target the immune-mediated control of tumor progression. In this report we investigated the role of SV40 Tag-specific CD8~+ T cells in the control of advanced choroid plexus tumor progression using large tumor Ag (Tag) transgenic mice. Since mice of the SV11 line are tolerant to the immunodominant SV40 Tag-derived CTL epitopes, mice with advanced stage tumors were reconstituted with naive C57BL/6 spleen cells following a low dose of #gamma#-irradiation. This led to the priming of CTLs specific for the H2-K~b-restricted epitope IV by the endogenous Tag and a significant increase in the life span of Tag transgenic mice. Epitope IV-specific CD8~+ T cells accumulated and persisted in the brains and tumors of SV11 mice, as determined by analysis with epitope-specific MHC class I tetramers. Brain-infiltrating epitope IV-specific T cells were capable of producing IFN-#gamma# as well as lysing syngeneic Tag-transformed cells in vcitro. In addition, the adoptive transfer of spleen cells from Tag-immune C57BL/6 mice resulted in a dramatic increase in the control of tumor progression in SV11 mice and was associated with the accumulation of CD8~+ T cells specific for multiple Tag epitopes in the brain. These results indicate that the control of advanced stage spontaneous choroid plexus tumors is associated with the induction of a strong and persistent CD8~+ T cell response to Tag.
机译:由于癌蛋白的转基因表达而自发产生肿瘤的小鼠模型提供了机会来测试靶向免疫介导的肿瘤进展控制的方法。在本报告中,我们使用大型肿瘤Ag(Tag)转基因小鼠研究了SV40标签特异性CD8〜+ T细胞在控制脉络丛神经进展中的作用。由于SV11系的小鼠对SV40标签衍生的免疫显性CTL表位具有耐受性,因此在低剂量的#γ#辐照后,具有初次肿瘤的小鼠将用天然C57BL / 6脾细胞进行重建。这导致通过内源性标签引发对H2-Kb限制的表位IV具有特异性的CTL,并且标签转基因小鼠的寿命显着增加。抗原决定簇IV特异性CD8〜+ T细胞在SV11小鼠的大脑和肿瘤中积累并持续存在,这是通过抗原决定簇特异性MHC I类四聚体的分析确定的。脑浸润的抗原决定簇IV特异性T细胞能够产生IFN-#γ#,并能在体外分离裂解同质的Tag转化细胞。此外,从具有Tag免疫力的C57BL / 6小鼠脾脏细胞的过继转移导致SV11小鼠对肿瘤进展的控制显着增加,并且与特异性针对多个Tag表位的CD8〜+ T细胞的积累有关。脑。这些结果表明,晚期自发性脉络丛神经瘤的控制与诱导对Tag的强而持久的CD8 + T细胞应答有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号